ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,097Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 307

$558K Total Retail Price of All Prescriptions

Rank: 15 out of 307

517 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,932 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
OMEPRAZOLE 540 376 1 5
SIMVASTATIN 486 406 2 2
FUROSEMIDE 483 401 3 6
LISINOPRIL 444 362 4 3
HYDROCODONE-ACETAMINOPHEN 433 326 S3 5 4
LEVOTHYROXINE SODIUM 422 332 6 1
METOPROLOL TARTRATE 345 292 7 12
CITALOPRAM HBR 302 214 8 14
METFORMIN HCL 262 196 9 8
TRAMADOL HCL 218 147 10 25
POTASSIUM CHLORIDE 217 178 11 10
CEPHALEXIN 216 154 12 95
WARFARIN SODIUM 214 141 13 11
RISPERIDONE 206 139 14 62
HYDROCHLOROTHIAZIDE 189 165 15 9
AMLODIPINE BESYLATE 188 176 16 7
LOSARTAN POTASSIUM 180 173 17 16
ATORVASTATIN CALCIUM 168 141 18 18
MELOXICAM 164 118 19 29
ALLOPURINOL 163 114 20 27
METOPROLOL SUCCINATE 153 146 21 13
ACETAMINOPHEN-CODEINE 139 94 S3 22 86
ATENOLOL 132 94 23 17
ZOLPIDEM TARTRATE 126 109 24 19
TRIAMTERENE-HCTZ 122 110 25 42
CARBAMAZEPINE 113 25 26 148
ALENDRONATE SODIUM 113 98 26 20
SERTRALINE HCL 112 76 28 22
RANITIDINE HCL 109 89 29 57
TRAZODONE HCL 108 73 30 33
CIPROFLOXACIN HCL 106 93 31 83
DONEPEZIL HCL 103 103 32 34
AMLODIPINE BESYLATE-BENAZEPRIL 97 76 33 136
GABAPENTIN 96 69 34 15
PREDNISONE 94 88 35 37
NEXIUM 89 36 36 38
OXYBUTYNIN CHLORIDE 86 70 37 87
KLOR-CON 10 84 67 38 95
PHENYTOIN SODIUM EXTENDED 82 39 39 101
GLIPIZIDE 79 51 40 71
DIVALPROEX SODIUM 78 56 41 67
FLUOXETINE HCL 77 22 42 32
PAROXETINE HCL 75 63 43 43
PROAIR HFA 71 50 44 53
DIOVAN 68 68 45 58
CLOPIDOGREL 66 60 46 59
ALBUTEROL SULFATE 65 65 47 118
SPIRONOLACTONE 64 48 48 40
CARVEDILOL 63 50 49 24
ROPINIROLE HCL 62 44 50 74
KLOR-CON M20 60 39 51 64
SINGULAIR 58 36 52 100
SYNTHROID 58 41 52 85
AMITRIPTYLINE HCL 58 33 R 52 65
DIGOXIN 57 45 55 36
ISOSORBIDE MONONITRATE ER 57 57 55 78
BENAZEPRIL HCL 56 56 57 73
JANUVIA 53 53 58 97
METOCLOPRAMIDE HCL 52 27 59 108
TAMSULOSIN HCL 51 51 60 21
GEMFIBROZIL 51 38 60 69
OLANZAPINE 50 31 62 70
PLAVIX 50 50 62 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.